Archives

by in
Entry Author Date Location
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections 05/22/13 Seattle
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS 05/02/13 Texas
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Boston: Reclaiming Its Place as a Technology Hub 04/26/13 Boston
East Coast Biotech Roundup: Biogen Idec, Third Rock, T2 Bio, Dart 03/29/13 Boston
Biogen Idec Wins FDA Approval For Oral Multiple Sclerosis Drug 03/27/13 Boston
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
Blueprint Medicines Combs Through Genome for the Next Gleevec(s) 03/20/13 Boston
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Protein Sciences’ Pitch: a “Pure” Flu Vaccine Alternative 03/11/13 New York
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
Corporate Compliance Programs: The Importance of Being Effective 02/15/13 National
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
Ironwood Bucks the Trends, Makes Big Bet on Drug For Millions 02/06/13 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 01/10/13 San Francisco
2012: The Year When Genomic Medicine Started Paying Off 12/17/12 National
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? 05/03/12 Seattle
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers 04/20/12 Boston
Boston and Cambridge Renew Rivalry in Startup Real Estate 04/13/12 Boston
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
Biotech’s New Frontier: Europe? 03/19/12 National
Enanta, Satori, Vertex & More of the Week’s Life Sciences Newsmakers 02/24/12 Boston
Page 1 of 10 next page »